Magazine Article | June 1, 2018

Pharma Needs A New Business Model

Source: Life Science Leader

By Gail Dutton, Contributing Writer
Follow Me On Twitter @GailLdutton

Life sciences companies need new business models if they expect to succeed in a disruptive, tech-based environment. Integrating technologies that enable a company to achieve its goals requires new ways of thinking, according to EY Progressions 2018 report Life Sciences 4.0: Securing value through data-driven platforms.

The key isn’t merely to add digital components to the overall corporate strategy, but to rethink what’s possible because of new technological capabilities and to use those insights to further your business strategy and to help you respond to a dynamic marketplace. “Companies must either use the advances in technology to unlock insights from data from within the organization and from throughout the industry or be left behind,” says Pamela Spence, EY global life sciences industry leader.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader